Facile preparation of an orthogonally protected, pH-sensitive, bioconjugate linker for therapeutic applications

Organic Letters

Volumn 6, Issue 23, 2004, Pages 4245-4248

  Fletcher, Steven ^a,c   Jorgensen, Michael R ^b   Miller, Andrew D ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IC Vec Ltd   (United Kingdom)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID ANHYDRIDE; PHOSPHOLIPID;

ARTICLE; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; PH MEASUREMENT; SYNTHESIS;

EID: 9444277152     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0483347     Document Type: Article

References (24)

1. Felgner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Chan, H. W.; Wenz, M.; Northrop, J. P.; Ringold, G. M.; Danielsen, M. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 7413-7417.
2. Litzinger, D. C.; Huang, L. Biochim. Biophys. Acta 1992, 1113, 201-227.
3. Gruner, S. M.; Cullis, P. R.; Hope, M. J.; Tilcock, C. P. Annu. Rev. Biophys. Biophys. Chem. 1985, 28, 211-238.
4. Felgner, J. H.; Kumar, R.; Sridhar, C. N.; Wheeler, C. J.; Tsai, Y. J.; Border, R.; Ramsey, P.; Martin, M.; Felgner, P. L. J. Biol. Chem. 1994, 269, 2550-2561.
5. Farhood, H.; Serbina, N.; Huang, L. Biochim. Biophys. Acta 1995, 1235, 289-295.
6. Siegel, D. P.; Epand, R. M. Biophys. J. 1997, 73, 3089-3111.
7. Keller, M.; Jorgensen, M. R.; Perouzel, E.; Miller, A. D. Biochemistry 2003, 42, 6067-6077.
8. Drummond, D. C.; Daleke, D. L. Chem. Phys. Lipids 1995, 75, 27-41.
9. Dixon, H. B.; Perham, R. N. Biochem. J. 1968, 109, 312-314.
10. Bender, M. L. J. Am. Chem. Soc. 1957, 79, 1258-1259.
11. Hafez, I. M.; Maurer, N.; Cullis, P. R. Gene Ther. 2001, 8, 1188-1196.
12. Shen, W. C.; Ryser, H. J. P. Biochem. Biophys. Res. Commun. 1981, 102, 1048-1054.
13. Remenyi, J.; Balazs, B.; Toth, S.; Falus, A.; Toth, G.; Hudecz, F. Biochem. Biophys. Res. Commun. 2003, 303, 556-561.
14. Dinand, E.; Zloh, M.; Brocchini, S. Aust. J. Chem. 2002, 55, 467-474.
15. Wasserman, H. H.; Ho, W.-B. J. Org. Chem. 1994, 59, 4364-4366.
16. 3). These observations are in agreement with similar functionalities in the literature: Hosseine Massoudi, H.; Cantacuzene, D.; Wakselman, C.; Bouthier de la Tour, C. Synthesis 1983, 12, 1010-1012. The NOE spectrum of 8 is available in Supporting Information.
17. Gibson, F. S.; Bergmeier, S. C.; Rapoport, H. J. Org. Chem. 1994, 59, 3216-3218.
18. Kichler, A. J. Gene Med. 2004, 6, S3-S10.
19. Giannis, A.; Sandhoff, K. Tet. Lett. 1985, 26, 1479-1482.
20. Gustafsson, T.; Saxin, M.; Kihlberg, J. J. Org. Chem. 2003, 68, 2506-2509.
21. Liptak, A.; Nanasi, P.; Neszmelyi, A.; Wagner, H. Carbohydr. Res. 1980, 86, 133-136.
22. To the best of our knowledge, this is the first report of a di-Fmoc-protected pyranoside.
23. II Phase Transition Temperature - Implications for Cationic Liposome-Based Gene Delivery; Fletcher, S.; Jorgensen, M. R.; Miller, A. D. Submitted.
24. 3)).